Brod M, Hojbjerre L, Adalsteinsson JE, Rasmussen MH. Assessing the impact of growth hormone deficiency and treatment in adults: development of a new disease-specific measure. J Clin Endocrinol Metab. 2014 Apr. 99 (4):1204-12. [QxMD MEDLINE Link]. [Full Text].
Tanriverdi F, Schneider HJ, Aimaretti G, Masel BE, Casanueva FF, Kelestimur F. Pituitary dysfunction after traumatic brain injury: a clinical and pathophysiological approach. Endocr Rev. 2015 Jun. 36 (3):305-42. [QxMD MEDLINE Link]. [Full Text].
Tanriverdi F, Kelestimur F. Neuroendocrine disturbances after brain damage: an important and often undiagnosed disorder. J Clin Med. 2015 Apr 28. 4 (5):847-57. [QxMD MEDLINE Link]. [Full Text].
Guaraldi F, Grottoli S, Arvat E, Ghigo E. Hypothalamic-pituitary autoimmunity and traumatic brain injury. J Clin Med. 2015 May 19. 4 (5):1025-35. [QxMD MEDLINE Link]. [Full Text].
Melmed S. Idiopathic adult growth hormone deficiency. J Clin Endocrinol Metab. 2013 Jun. 98 (6):2187-97. [QxMD MEDLINE Link]. [Full Text].
[Guideline] Allen DB, Backeljauw P, Bidlingmaier M, et al. GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults. Eur J Endocrinol. 2016 Feb. 174 (2):P1-9. [QxMD MEDLINE Link]. [Full Text].
[Guideline] Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML, Endocrine Society. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011 Jun. 96 (6):1587-609. [QxMD MEDLINE Link]. [Full Text].
Stochholm K, Gravholt CH, Laursen T, et al. Incidence of GH deficiency - a nationwide study. Eur J Endocrinol. 2006 Jul. 155 (1):61-71. [QxMD MEDLINE Link].
Mo D, Blum WF, Rosilio M, Webb SM, Qi R, Strasburger CJ. Ten-year change in quality of life in adults on growth hormone replacement for growth hormone deficiency: an analysis of the hypopituitary control and complications study. J Clin Endocrinol Metab. 2014 Dec. 99 (12):4581-8. [QxMD MEDLINE Link].
Biller BM, Samuels MH, Zagar A, et al. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab. 2002 May. 87 (5):2067-79. [QxMD MEDLINE Link].
US Food and Drug Administration. NDA approval [letter]. NDA 205598. Available at https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/205598Orig1s000ltr.pdf. December 20, 2017; Accessed: January 8, 2018.
Macrilen (macimorelin) [package insert]. Goettingen, Germany: Aeterna Zentaris GmbH. Revised January 2018. Available at [Full Text].
Garcia JM, Biller BMK, Korbonits M, et al. Macimorelin as a diagnostic test for adult growth hormone deficiency. J Clin Endocrinol Metab. 2018 May 31. [QxMD MEDLINE Link].
Cook DM, Yuen KC, Biller BM, Kemp SF, Vance ML, American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update. Endocr Pract. 2009 Sep-Oct. 15 suppl 2:1-29. [QxMD MEDLINE Link].
[Guideline] Yuen KC, Tritos NA, Samson SL, Hoffman AR, Katznelson L. American Association of Clinical Endocrinologists and American College of Endocrinology Disease state clinical review: update on growth hormone stimulation testing and proposed revised cut-point for the glucagon stimulation test in the diagnosis of adult growth hormone deficiency. Endocr Pract. 2016 Oct. 22 (10):1235-44. [QxMD MEDLINE Link]. [Full Text].
Hoffman AR, Strasburger CJ, Zagar A, Blum WF, Kehely A, Hartman ML, et al. Efficacy and tolerability of an individualized dosing regimen for adult growth hormone replacement therapy in comparison with fixed body weight-based dosing. J Clin Endocrinol Metab. 2004 Jul. 89 (7):3224-33. [QxMD MEDLINE Link].
Arnold JR, Arnold DF, Marland A, Karavitaki N, Wass JA. GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence. Clin Endocrinol (Oxf). 2009 Mar. 70 (3):435-8. [QxMD MEDLINE Link].
Buchfelder M, Kann PH, Wuster C, et al. Influence of GH substitution therapy in deficient adults on the recurrence rate of hormonally inactive pituitary adenomas: a case control study. Eur J Endocrinol. 2007 Aug. 157 (2):149-56. [QxMD MEDLINE Link].
Karavitaki N, Warner JT, Marland A, et al. GH replacement does not increase the risk of recurrence in patients with craniopharyngioma. Clin Endocrinol (Oxf). 2006 May. 64 (5):556-60. [QxMD MEDLINE Link].
Jenkins PJ, Mukherjee A, Shalet SM. Does growth hormone cause cancer?. Clin Endocrinol (Oxf). 2006 Feb. 64 (2):115-21. [QxMD MEDLINE Link].
Poidvin A, Carel JC, Ecosse E, Levy D, Michon J, Coste J. Increased risk of bone tumors after growth hormone treatment in childhood: A population-based cohort study in France. Cancer Med. 2018 Jun 14. [QxMD MEDLINE Link].
Holmes SJ, Shalet SM. Which adults develop side-effects of growth hormone replacement?. Clin Endocrinol (Oxf). 1995 Aug. 43 (2):143-9. [QxMD MEDLINE Link].
Maison P, Griffin S, Nicoue-Beglah M, Haddad N, Balkau B, Chanson P. Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a meta-analysis of blinded, randomized, placebo-controlled trials. J Clin Endocrinol Metab. 2004 May. 89 (5):2192-9. [QxMD MEDLINE Link].
Losa M, Scavini M, Gatti E, et al. Long-term effects of growth hormone replacement therapy on thyroid function in adults with growth hormone deficiency. Thyroid. 2008 Dec. 18 (12):1249-54. [QxMD MEDLINE Link].
Giavoli C, Libe R, Corbetta S, et al. Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients. J Clin Endocrinol Metab. 2004 Nov. 89 (11):5397-401. [QxMD MEDLINE Link].
Giannoulis MG, Sonksen PH, Umpleby M, et al. The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. J Clin Endocrinol Metab. 2006 Feb. 91 (2):477-84. [QxMD MEDLINE Link].
Cook DM, Ludlam WH, Cook MB. Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults. J Clin Endocrinol Metab. 1999 Nov. 84 (11):3956-60. [QxMD MEDLINE Link].
Chikani V, Cuneo RC, Hickman I, Ho KK. Growth hormone (GH) enhances anaerobic capacity: impact on physical function and quality of life in adults with GH deficiency. Clin Endocrinol (Oxf). 2016 Oct. 85 (4):660-8. [QxMD MEDLINE Link].
van Bunderen CC, van Varsseveld NC, Erfurth EM, Ket JC, Drent ML. Efficacy and safety of growth hormone treatment in adults with growth hormone deficiency: a systematic review of studies on morbidity. Clin Endocrinol (Oxf). 2014 Jul. 81 (1):1-14. [QxMD MEDLINE Link].
Rosilio M, Blum WF, Edwards DJ, et al. Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H). J Clin Endocrinol Metab. 2004 Apr. 89 (4):1684-93. [QxMD MEDLINE Link].
Cuneo RC, Salomon F, McGauley GA, Sonksen PH. The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf). 1992 Nov. 37 (5):387-97. [QxMD MEDLINE Link].
De Boer H, Blok GJ, Voerman HJ, De Vries PM, van der Veen EA. Body composition in adult growth hormone-deficient men, assessed by anthropometry and bioimpedance analysis. J Clin Endocrinol Metab. 1992 Sep. 75 (3):833-7. [QxMD MEDLINE Link].
Gazzaruso C, Gola M, Karamouzis I, Giubbini R, Giustina A. Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH--an update. J Clin Endocrinol Metab. 2014 Jan. 99 (1):18-29. [QxMD MEDLINE Link].
Svensson J, Bengtsson BA, Rosen T, Oden A, Johannsson G. Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. J Clin Endocrinol Metab. 2004 Jul. 89 (7):3306-12. [QxMD MEDLINE Link].
Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990 Aug 4. 336 (8710):285-8. [QxMD MEDLINE Link].
Jorgensen JOL, Juul A. Therapy of endocrine disease: growth hormone replacement therapy in adults: 30 years of personal clinical experience. Eur J Endocrinol. 2018 Jul. 179 (1):R47-56. [QxMD MEDLINE Link].
Verhelst J, Mattsson AF, Camacho-Hubner C, Luger A, Abs R. The prevalence of the metabolic syndrome and associated cardiovascular complications in adult-onset GHD during GH replacement: a KIMS analysis. Endocr Connect. 2018 May. 7 (5):653-62. [QxMD MEDLINE Link].
McCallum RW, Petrie JR, Dominiczak AF, Connell JM. Growth hormone deficiency and vascular risk. Clin Endocrinol (Oxf). 2002 Jul. 57 (1):11-24. [QxMD MEDLINE Link].
Colao A, Di Somma C, Rota F, et al. Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency. J Clin Endocrinol Metab. 2005 Apr. 90 (4):2056-62. [QxMD MEDLINE Link].
Cannavo S, Marini F, Curto L, et al. High prevalence of coronary calcifications and increased risk for coronary heart disease in adults with growth hormone deficiency. J Endocrinol Invest. 2011 Jan. 34 (1):32-7. [QxMD MEDLINE Link].
Colao A, Di Somma C, Spiezia S, et al. Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency. J Clin Endocrinol Metab. 2008 Sep. 93 (9):3416-24. [QxMD MEDLINE Link].
Maison P, Chanson P. Cardiac effects of growth hormone in adults with growth hormone deficiency: a meta-analysis. Circulation. 2003 Nov 25. 108 (21):2648-52. [QxMD MEDLINE Link].
Wuster C, Abs R, Bengtsson BA, et al, for the KIMS Study Group and the KIMS International Board, Pharmacia Upjohn International Metabolic Database. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res. 2001 Feb. 16 (2):398-405. [QxMD MEDLINE Link].
Appelman-Dijkstra NM, Claessen KM, Hamdy NA, Pereira AM, Biermasz NR. Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with growth hormone deficiency (GHD): the Leiden Cohort Study. Clin Endocrinol (Oxf). 2014 Nov. 81 (5):727-35. [QxMD MEDLINE Link].
Snyder PJ, Biller BM, Zagar A, et al. Effect of growth hormone replacement on BMD in adult-onset growth hormone deficiency. J Bone Miner Res. 2007 May. 22 (5):762-70. [QxMD MEDLINE Link].
Bex M, Abs R, Maiter D, Beckers A, Lamberigts G, Bouillon R. The effects of growth hormone replacement therapy on bone metabolism in adult-onset growth hormone deficiency: a 2-year open randomized controlled multicenter trial. J Bone Miner Res. 2002 Jun. 17 (6):1081-94. [QxMD MEDLINE Link].
Pappachan JM, Raskauskiene D, Kutty VR, Clayton RN. Excess mortality associated with hypopituitarism in adults: a meta-analysis of observational studies. J Clin Endocrinol Metab. 2015 Apr. 100 (4):1405-11. [QxMD MEDLINE Link].
Thilmany S, Mchirgui L, Brunelle C, Beauloye V, Maiter D, Alexopoulou O. Correlation between the responses to growth hormone (GH) treatment during childhood and adulthood in a monocentric cohort of GH-deficient patients. Horm Metab Res. 2018 Jun. 50 (6):462-8. [QxMD MEDLINE Link].
Sherlock M, Ayuk J, Tomlinson JW, et al. Mortality in patients with pituitary disease. Endocr Rev. 2010 Jun. 31 (3):301-42. [QxMD MEDLINE Link].
Bates AS, Van't Hoff W, Jones PJ, Clayton RN. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab. 1996 Mar. 81 (3):1169-72. [QxMD MEDLINE Link].
Rosen T, Wiren L, Wilhelmsen L, Wiklund I, Bengtsson BA. Decreased psychological well-being in adult patients with growth hormone deficiency. Clin Endocrinol (Oxf). 1994 Jan. 40 (1):111-6. [QxMD MEDLINE Link].
Hartman ML, Crowe BJ, Biller BM, et al, for the HyposCCS Advisory Board, US HypoCCS Study Group. Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?. J Clin Endocrinol Metab. 2002 Feb. 87 (2):477-85. [QxMD MEDLINE Link].
Darzy KH, Aimaretti G, Wieringa G, Gattamaneni HR, Ghigo E, Shalet SM. The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. J Clin Endocrinol Metab. 2003 Jan. 88 (1):95-102. [QxMD MEDLINE Link].
Mavromati M, Kuhn E, Agostini H, et al. Classification of patients with GH disorders may vary according to the IGF-I assay. J Clin Endocrinol Metab. 2017 Aug 1. 102 (8):2844-52. [QxMD MEDLINE Link].
[Guideline] Fleseriu M, Hashim IA, Karavitaki N, et al. Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016 Nov. 101 (11):3888-921. [QxMD MEDLINE Link]. [Full Text].
Brod M, Beck JF, Hojbjerre L, et al. Assessing the impact of growth hormone deficiency (GHD) in adults: interpreting change of the treatment-related impact measure-adult growth hormone deficiency (TRIM-AGHD). Pharmacoecon Open. 2018 May 23. [QxMD MEDLINE Link].
Ramos-Levi AM, Marazuela M. Treatment of adult growth hormone deficiency with human recombinant growth hormone: an update on current evidence and critical review of advantages and pitfalls. Endocrine. 2018 May. 60 (2):203-18. [QxMD MEDLINE Link].
Johannsson G, Feldt-Rasmussen U, Hakonsson IH, et al, for the REAL 2 Study Group. Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial. Eur J Endocrinol. 2018 May. 178 (5):491-9. [QxMD MEDLINE Link].